In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces

BACKGROUND: Drug repositioning refers to the identification of new indications for existing drugs. Drug-based inference methods for drug repositioning apply some unique features of drugs for new indication prediction. Complementary information is provided by these different features. It is therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hailin, Zhang, Zuping, Zhang, Jingpu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868667/
https://www.ncbi.nlm.nih.gov/pubmed/33557749
http://dx.doi.org/10.1186/s12859-021-03988-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868667/
https://www.ncbi.nlm.nih.gov/pubmed/33557749
http://dx.doi.org/10.1186/s12859-021-03988-x

Ejemplares similares